Featured

Three Exercises That Benefit People With MS

January 13, 2012
By
Three Exercises That Benefit People With MS

Multiple sclerosis can cause the muscular system to atrophy.  However, a person with this disease can learn to manage their pain and help their body stay strong by the use of exercise. Exercise can help the body become stronger and will combat muscle atrophy. This, in turn, reduces the symptoms of Multiple Sclerosis. With...

Read more »

New Genetic Discovery Could Bring Us Closer to Cure

January 8, 2012
By
New Genetic Discovery Could Bring Us Closer to Cure

According to a meta-analysis that was published in December’s “Annals of Neurology,” three new multiple sclerosis genetic susceptibility loci have now been identified. Nikolaos A. Patsopoulos, M.D. and Ph.D., along with colleagues, had been investigating MS susceptibility. To find the consequences of novel susceptibility loci, a one-stage meta-analysis was done. There were seven genome-wide...

Read more »

New Cambridge University research offers hope for MS sufferers

January 7, 2012
By
New Cambridge University research offers hope for MS sufferers

A recently released Cambridge University study offered hope for those suffering from the ill effects of MS, multiple sclerosis, which is a degenerative muscular disorder. The study showed that through stem cell and remyelination therapy could be beneficial in restoring the damaged nerves throughout the body, even in sufferers of MS at more advanced...

Read more »

New model to test new cures

January 7, 2012
By
New model to test new cures

Each day is a new day of discovery in the world of science. This makes it quite interesting and intriguing at the same time. In humans there’s a condition that inhibits the transfer of neurons or signals leading to distressing disabilities. They usually lead to active sessions of MS that last for almost 2...

Read more »

New virus link could lead to cure

January 6, 2012
By
New virus link could lead to cure

Exciting new studies in the medical community have formed a possible link between a virus and MS. The implications are monumental, suggesting a possibility for prevention of the disease as well as a cure. Scientific research was conducted at the Queen Mary university in London and published in the scientific journal, Neurology. Scientists focused...

Read more »

MS might not be autoimmune disease afterall

January 3, 2012
By

Multiple sclerosis affects more women than men. Doctors have long believed that the disease is an auto-immune condition. New research suggest the disease is not an auto-immune condition. Instead, MS would be caused by faulty lipid metabolism. The degenerative disease causes inflammation and leads to scarring. The scarring can cause profound neurological and nerve...

Read more »

Brain stimulation research shows promising results

December 30, 2011
By
Brain stimulation research shows promising results

A 26-patient clinical trial completed double-blinded at has provided Brainsway Ltd. the results assessing the safety and effectiveness of its Deep TMS device used in treating patients with MS (multiple sclerosis). The trial participants were separated into three groups: a treatment group receiving 18 Hz, (high-frequency) left pre-frontal stimulation, a control group with false-stimulation,...

Read more »

New MS Drug Shows Great Success Rate

December 26, 2011
By
New MS Drug Shows Great Success Rate

A woman named Jennifer Garner was diagnosed with multiple sclerosis in 2004 after losing the sensation of feeling in the entire left side of her body. The drug Rebif provided relief for a short time until her illness progressed to a point at which Rebif could no longer work to combat the symptoms of...

Read more »

Wine is good for MS

December 21, 2011
By
Wine is good for MS

A research team in Belgium found that wine may slow the progression of multiple sclerosis (MS). Though reasons for the effects were unclear, the team found that patients who suffer from MS relapse and also drank wine, had less severe symptoms. MS is an autoimmune disease that greatly affects the central nervous system. The...

Read more »

Gilenya trial finishes with promising results for RRMS sufferers

December 21, 2011
By
Gilenya trial finishes with promising results for RRMS sufferers

After a two-year, randomized, control study of 2,000+ RRMS patients, drugmaker Novartis announced promising findings. Patients taking a once-daily oral dose of fingolimod saw a decrease of almost half in annual relapse rates of RRMS. This reduction in attacks resulted in patients with a better-functioning nervous system than the unmedicated control. In addition, the...

Read more »